A European survey of diagnostic methods and testing protocols for Clostridium difficile

Area of Science:

• Clinical microbiology
• Infectious diseases
• European healthcare systems

Background:

• Clostridium difficile infection (CDI) diagnosis is crucial for patient outcomes.
• Variations in diagnostic practices can impact treatment and epidemiology.

Purpose of the Study:

• To survey diagnostic methods for Clostridium difficile in European clinical microbiology laboratories.
• To identify discrepancies in diagnostic approaches across different countries.

Main Methods:

• A questionnaire was distributed to clinical microbiology laboratories in eight European countries.
• Laboratories were selected based on hospital bed count (1 per 10,000 beds).
• The survey covered diagnostic criteria, methods, and circumstances of requests for C. difficile testing.

Main Results:

• 212 laboratories participated; 87.7% routinely performed C. difficile tests.
• Toxin detection (93%) was most common, followed by culture (55%) and GDH (5.9%).
• Significant inter-country discrepancies in diagnostic strategies were observed, with 4.8% deemed suboptimal.

Conclusions:

• Marked discrepancies exist in C. difficile investigation criteria and diagnostic methods across European laboratories and countries.
• Lack of clear national guidelines and varying physician emphasis on C. difficile contribute to these variations.
• Standardized guidelines are essential for accurate comparison of CDI incidence and epidemiology.